Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
Loading...
Embargo End Date
Authors
Larkin, J
Marais, R
Porta, N
de Castro, DG
Parsons, L
Messiou, C
Stamp, G
Thompson, L
Edmonds, K
Sarker, S
Banerji, J
Lorigan, P
Evans, TRJ
Corrie, P
Marshall, E
Middleton, MR
Nathan, P
Nicholson, S
Ottensmeier, C
Plummer, R
Bliss, J
Valpione, S
Turajlic, S
Marais, R
Porta, N
de Castro, DG
Parsons, L
Messiou, C
Stamp, G
Thompson, L
Edmonds, K
Sarker, S
Banerji, J
Lorigan, P
Evans, TRJ
Corrie, P
Marshall, E
Middleton, MR
Nathan, P
Nicholson, S
Ottensmeier, C
Plummer, R
Bliss, J
Valpione, S
Turajlic, S
Document Type
Journal Article
Date
2024-03-19
Date Accepted
2024-01-26
Abstract
Citation
Cell Reports Medicine,
DOI
Source Title
Cell Reports Medicine
Publisher
CELL PRESS
ISSN
2666-3791
eISSN
2666-3791
2666-3791
2666-3791
Collections
Research Team
Clin Trials & Stats Unit